Pricing Log in Create free account
Monday 9 November 2026 Export AYTU’s income statement to Excel — free account

Aytu BioPharma, Inc.

AYTU

Healthcare Drug Manufacturers Specialty & Generic

Aytu BioPharma, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $57.6 million, down 13.3% from fiscal 2025.

Revenue
+6.42%
EPS
+100.0%
Free cash flow
+57.7%
Total debt
−21.9%

Quarter to June 2026, against a year earlier

1.83 0.02 +1.10%
Market cap
$19.9M
P/E
n/m
Fwd P/E
n/m
Dividend yield
—
F-score
3/9
ROIC
−20.0%
Net debt / EBITDA
2.2×
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Aytu BioPharma, Inc. (AYTU) EV/Sales

Alert me on EV/Sales

As of 6 November 2026, Aytu BioPharma, Inc. (AYTU) trades at a EV/Sales of 0.2×. Over the past ten years it has ranged from −28.1× (September 2015) to 1,335,254,036× (April 2015); the current reading is higher than 49% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 2.8× and below the Healthcare sector median of 3.6×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2026 0.3× 335.86%
FY2025 0.1× (59.00%)
FY2024 0.2× —
FY2023 0.0× —
FY2022 0.2× (77.93%)
FY2021 0.9× (18.44%)
FY2020 1.1× (8.82%)
FY2019 1.2× —
FY2018 −1.0× —
FY2017 33.4× —

Quarterly newest first

Period EV/Sales Change
Jun 2026 0.3× (28.89%)
Mar 2026 0.4× 54.94%
Dec 2025 0.3× 40.62%
Sep 2025 0.2× 181.34%
42 more quarters

Against its own ten years

Low −28.1× High 1,335,254,036×
Ten-year median 0.2×
Current reading's percentile 36

EV/Sales against peers

Company EV/Sales
IXHL Incannex Healthcare Inc. compare −24.2×
OPTH Optimi Health Corp. compare n/m
SHPH Shuttle Pharmaceuticals Holdings, Inc. compare n/m
RMTI Rockwell Medical, Inc. compare 0.2×
AYTU Aytu BioPharma, Inc. 0.2×
BFRI Biofrontera Inc. compare 0.2×
SCYX SCYNEXIS, Inc. compare 0.6×
CPHI China Pharma Holdings, Inc. compare 6.7×
TXMD TherapeuticsMD, Inc. compare 84.5×
Drug Manufacturers Specialty & Generic industry median 2.8×
Healthcare sector median 3.6×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on AYTU